Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raptiva and Sirolimus in Type 1 Diabetic Islet Allograft Recipients
NCT00672204Phase 2Terminated
- Sponsor
- University of Minnesota
- Start
- Nov 2007
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of efalizumab in type 1 diabetes mellitus (T1D), sponsored by University of Minnesota. Started Nov 2007; status: terminated.
02
Drugs
efalizumab
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00672204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672204.